Reassessment of omalizumab-dosing strategies and pharmacodynamics in inner-city children and adolescents

Authors

Christine A. Sorkness, University of Wisconsin
Jeremy J. Wildfire, Rho Federal Systems Division, Inc, Chapel Hill, NC
Agustin Calatroni, Rho Federal Systems Division, Inc, Chapel Hill, NC
Herman E. Mitchell, Rho Federal Systems Division, Inc, Chapel Hill, NCFollow
William W. Busse, University of Wisconsin
George T. O'Connor, Boston University
Jacqueline A. Pongracic, Children's Memorial Hospital, Chicago, IL
Kristie Ross, Case Western Reserve University
Michelle A. Gill, University of Texas Southwestern Medical Center at Dallas
Meyer Kattan, Columbia University
Wayne J. Morgan, University of Arizona
Stephen J. Teach, George Washington UniversityFollow
Peter J. Gergen, National Institute of Allergy and Infectious Diseases, Bethesda, MD
Andrew H. Liu, University of Colorado
Stanley J. Szefler, University of Colorado

Document Type

Journal Article

Publication Date

3-2013

Journal

Journal of Allergy and Clinical Immunology: In Practice

Volume

Volume 1, Issue 2

Inclusive Pages

163-171

Keywords

Anti-Asthmatic Agents--administration & dosage; Antibodies, Anti-Idiotypic--administration & dosage; Antibodies, Monoclonal, Humanized--administration & dosage; Asthma--drug therapy

APA Citation

Sorkness, C. A., Wildfire, J. J., Calatroni, A., Mitchell, H. E., Busse, W. W., O'Connor, G. T., Pongracic, J.A., Ross, K., Gill, M.A., Kattan, M., Morgan, W.J., Teach, S.J., Gergen, P.J., Liu, A.H., Szefler, S. J. (2013). Reassessment of omalizumab-dosing strategies and pharmacodynamics in inner-city children and adolescents. Journal of Allergy and Clinical Immunology: In Practice, 1(2), 163-171.

Peer Reviewed

1